{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:08:30Z","timestamp":1788880110785,"version":"build-2803163510"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Plethora Solutions LTD"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.ejogrb.2011.07.030","type":"journal-article","created":{"date-parts":[[2011,8,13]],"date-time":"2011-08-13T13:51:56Z","timestamp":1313243516000},"page":"457-460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The efficacy and safety of PSD503 (phenylephrine 20%, w\/w) for topical application in women with stress urinary incontinence. A phase II, multicentre, double-blind, placebo controlled, 2-way cross over study"],"prefix":"10.1016","volume":"159","author":[{"given":"Dudley","family":"Robinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Cardozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Ellis-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pat","family":"Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Wyllie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2011.07.030_bib0005","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S0895-4356(00)00232-8","article-title":"A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT Study","volume":"53","author":"Hannestad","year":"2000","journal-title":"J Clin Epidem"},{"key":"10.1016\/j.ejogrb.2011.07.030_bib0010","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001842","article-title":"Adrenergic drugs for urinary incontinence in adults","volume":"2","author":"Alhasso","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2011.07.030_bib0015","unstructured":"Horwitz RI, Brass LM, Kernan WN, Viscoli CM. Phenylpropanolamine and risk of hemorrhagic stroke: final report of The Hemorrhagic Stroke Project May 10, 2000."},{"key":"10.1016\/j.ejogrb.2011.07.030_bib0020","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0022-3565(25)10548-X","article-title":"Effects of Duloxetine, a combined serotonin and norepineephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetised female cat","volume":"274","author":"Thor","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.ejogrb.2011.07.030_bib0025","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1067\/mob.2002.124840","article-title":"Duloxetine versus placebo in the treatment of stress urinary incontinence","volume":"187","author":"Norton","year":"2002","journal-title":"Am J Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2011.07.030_bib0030","first-page":"482","article-title":"Duloxetine vs. placebo in the treatment of stress urinary incontinence: a global phase III study","volume":"22","author":"Millard","year":"2003","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.ejogrb.2011.07.030_bib0035","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1471-0528.2007.01288.x","article-title":"Tolerability and efficacy of duloxetine in a non trial situation","volume":"114","author":"Duckett","year":"2007","journal-title":"BJOG"},{"key":"10.1016\/j.ejogrb.2011.07.030_bib0040","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00192-008-0564-4","article-title":"Duloxetine 1 year on: the longterm outcome of a cohort of women prescribed duloxetine","volume":"19","author":"Vella","year":"2008","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1016\/j.ejogrb.2011.07.030_bib0045","unstructured":"Leaker B. PE 301. A double-blind, 2-way crossover pilot study to compare the effects of topical phenylephrine gel with placebo on systemic blood pressure and intra-urethral pressure in patients with stress incontinence. Plethora Solutions Ltd. Internal report. 2001."},{"key":"10.1016\/j.ejogrb.2011.07.030_bib0050","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1046\/j.1365-2168.2000.01306.x","article-title":"Randomised controlled trial of topical phenylephrine in the treatment of faecal incontinence","volume":"87","author":"Carpeti","year":"2000","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejogrb.2011.07.030_bib0055","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.eururo.2004.04.018","article-title":"The standard 1-hour pad test: does it have any value in clinical practice?","volume":"46","author":"Abdel-Fattah","year":"2004","journal-title":"Euro Urol"},{"key":"10.1016\/j.ejogrb.2011.07.030_bib0060","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0090-4295(88)90462-1","article-title":"Pad-weighing test performed with standard bladder volume","volume":"32","author":"Lose","year":"1988","journal-title":"Urology"},{"key":"10.1016\/j.ejogrb.2011.07.030_bib0065","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1464-4096.2001.01548.x","article-title":"A new intravaginal device for stress incontinence in women","volume":"88","author":"Thyssen","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.ejogrb.2011.07.030_bib0070","first-page":"351","article-title":"A randomised cross over trial comparing oxybutynin taken three times a day or taken when needed","volume":"13","author":"Burton","year":"1994","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.ejogrb.2011.07.030_bib0075","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1464-410X.2004.04768.x","article-title":"Anti-diuresis \u2013 a new concept in the management of daytime urinary incontinence","volume":"93","author":"Robinson","year":"2004","journal-title":"BJU Int"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211511004519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211511004519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:28:18Z","timestamp":1788877698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211511004519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0301211511004519"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2011.07.030","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy and safety of PSD503 (phenylephrine 20%, w\/w) for topical application in women with stress urinary incontinence. A phase II, multicentre, double-blind, placebo controlled, 2-way cross over study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2011.07.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}